Endorphins Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type (Alpha-Endorphins, Beta-Endorphins, Gamma-Endorphins, Sigma-Endorphins); Application (Pain Management, cough suppression, Anesthesia, Others)
Report Code: TIPRE00013502 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Endorphins are chemicals which the body releases to reduce stress and pain. The function of these are closely to a medication class named opioids. Opioids are pain relievers that may cause euphoria. These are often administered during treatment for short-term usage or pain-relief. The term endorphin derives from bringing together "endogens," coming from inside the body, and "morphine," which is a pain relief for opiates. Endorphins have a mark since they are known pain relievers.
MARKET DYNAMICS
The Endorphins market is expected to grow significantly in the coming years, due to Increasing prevalence of cancer and chronic disorder. Moreover, chocolates containing flavonoids chemicals that appear to be beneficial to the brain is also anticipated to increase the demand for endorphins.
MARKET SCOPE
The "Endorphins Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Endorphins market with detailed market segmentation by product type and application. The Endorphins market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Endorphins market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Endorphins market is segmented on the basis of product type and application. Based on product type , the market is segmented into Alpha-endorphins, Beta-endorphins, Gamma-endorphins, Sigma-endorphins. On the basis of application , the market is categorized as Pain Management, cough suppression, Anesthesia, Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Endorphins market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Endorphins market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Endorphins market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Endorphins market in these regions.
The report covers key developments in the Endorphins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Endorphins market are anticipated to have lucrative growth opportunities in the future with the rising demand for Endorphins in the global market. Below mentioned is the list of few companies engaged in the Endorphins market.
The report also includes the profiles of key players in Endorphins market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Endorphins are chemicals which the body releases to reduce stress and pain. The function of these are closely to a medication class named opioids. Opioids are pain relievers that may cause euphoria. These are often administered during treatment for short-term usage or pain-relief. The term endorphin derives from bringing together "endogens," coming from inside the body, and "morphine," which is a pain relief for opiates. Endorphins have a mark since they are known pain relievers.
MARKET DYNAMICS
The Endorphins market is expected to grow significantly in the coming years, due to Increasing prevalence of cancer and chronic disorder. Moreover, chocolates containing flavonoids chemicals that appear to be beneficial to the brain is also anticipated to increase the demand for endorphins.
MARKET SCOPE
The "Endorphins Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Endorphins market with detailed market segmentation by product type and application. The Endorphins market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Endorphins market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Endorphins market is segmented on the basis of product type and application. Based on product type , the market is segmented into Alpha-endorphins, Beta-endorphins, Gamma-endorphins, Sigma-endorphins. On the basis of application , the market is categorized as Pain Management, cough suppression, Anesthesia, Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Endorphins market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Endorphins market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Endorphins market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Endorphins market in these regions.
The report covers key developments in the Endorphins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Endorphins market are anticipated to have lucrative growth opportunities in the future with the rising demand for Endorphins in the global market. Below mentioned is the list of few companies engaged in the Endorphins market.
The report also includes the profiles of key players in Endorphins market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Assertio Therapeutics Inc.,
- Cipher Pharmaceuticals Inc.,
- Endo International Plc,
- Egalet Corp.,
- Lannett Co. Inc.,
- Pfizer Inc.
- Johnson and Johnson.
- Remedee Labs
- Endorphin.es
- Wuhan Fine Biotech Co., Ltd
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
The List of Companies
1. Assertio Therapeutics Inc.,
2. Cipher Pharmaceuticals Inc.,
3. Endo International Plc,
4. Egalet Corp.,
5. Lannett Co. Inc.,
6. Pfizer Inc.
7. Johnson and Johnson.
8. Remedee Labs
9. Endorphin.es
10. Wuhan Fine Biotech Co., Ltd
1. Assertio Therapeutics Inc.,
2. Cipher Pharmaceuticals Inc.,
3. Endo International Plc,
4. Egalet Corp.,
5. Lannett Co. Inc.,
6. Pfizer Inc.
7. Johnson and Johnson.
8. Remedee Labs
9. Endorphin.es
10. Wuhan Fine Biotech Co., Ltd
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount